Calendar Madrigal Pharmaceuticals, Inc. Deutsche Boerse AG
Stocks
YDO1
US5588681057
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
15:55:02 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 445.70 EUR | +0.32% |
|
-0.93% | -10.00% |
| 09-24 | Analyst recommendations: Dropbox, Etsy, Meta Platforms, Okta, Rollins… |  |
| 09-23 | Citigroup Initiates Madrigal Pharmaceuticals at Buy With $725 Price Target | MT |
Chart calendar Madrigal Pharmaceuticals, Inc.
Upcoming events on Madrigal Pharmaceuticals, Inc.
No events available
Past events on Madrigal Pharmaceuticals, Inc.
| 2026-07-30 | Earnings presentation | 08:00 |
| 2026-07-30 | Earnings release - Q2 2026 | |
| 2026-06-17 | Annual General Meeting | 08:00 |
| 2026-06-17 | Présentation aux Actionnaires / Analystes | 08:00 |
| 2026-05-06 | Earnings release - Q1 2026 | |
| 2026-05-06 | Earnings presentation | 08:00 |
| 2026-02-19 | Earnings release - Q4 2025 | |
| 2026-02-19 | Earnings presentation | 08:00 |
| 2025-11-04 | Earnings release - Q3 2025 | |
| 2025-11-04 | Earnings presentation | 08:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 180 174 3.23% | 958 950 0.91% | 1 527 | 2 128 | 2 879 |
|
EBITDA Million USD | Released Forecast Spread | -380 -379 -0.29% | -497 -541 8.25% | -299 -297 -0.49% | -178 | 136 | 600 |
|
EBIT Million USD | Released Forecast Spread | -380 -372 -2.42% | -498 -537 7.21% | -300 -256 -17.27% | -187 | 167 | 682 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -374 -364 -2.75% | -466 -500 6.76% | -288 -241 -19.4% | -184 | 171 | 692 |
|
Net income Million USD | Released Forecast Spread | -374 -365 -2.29% | -466 -499 6.62% | -288 -238 -20.98% | -183 | 179 | 668 |
|
EPS USD | Released Forecast Spread | -20,0 -19,4 -2.78% | -21,9 -23,5 6.63% | -12,9 -10,8 -19.41% | -6,29 | 5,42 | 21,4 |
| Announcement Date | 28/02/24 | 26/02/25 | 19/02/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 103 97,8 5.64% | 137 114 20.2% | 213 162 31.22% | 287 248 15.97% | 321 313 2.67% | 311 301 3.46% | 364 353 3.14% | 405 | 446 | 434 | 502 | 571 | 634 |
|
EBITDA Million USD | Released Forecast Spread | -78,9 -117 32.8% | -46,8 -81,8 42.78% | -114 -32,6 -248.78% | -59,2 -104 43.13% | -55,9 -76,2 26.61% | -20,2 | -14,2 | -51,0 | -45,2 | ||||
|
EBIT Million USD | Released Forecast Spread | -67,0 -100 33.06% | -79,3 -95,4 16.83% | -47,2 -88,0 46.34% | -114 -44,7 -154.71% | -59,6 -15,8 -277.93% | -92,7 -98,7 6.09% | -56,3 -78,2 27.96% | -26,6 | -11,1 | -32,6 | 8,51 | 66,5 | 118 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -59,4 -91,7 35.23% | -73,2 -81,5 10.09% | -42,3 -82,7 48.89% | -114 -47,1 -142.21% | -58,6 -12,2 -380.49% | -94,4 -93,6 -0.8% | -57,9 -76,0 23.75% | -25,3 | -5,43 | -27,6 | 20,9 | 67,6 | 119 |
|
Net income Million USD | Released Forecast Spread | -59,4 -91,2 34.87% | -73,2 -82,7 11.47% | -42,3 -76,2 44.5% | -114 -55,5 -105.76% | -58,6 -9,48 -517.93% | -94,4 -93,7 -0.77% | -57,9 -75,1 22.86% | -25,7 | -7,47 | -27,6 | 20,5 | 66,0 | 117 |
|
EPS USD | Released Forecast Spread | -2,71 -4,10 33.91% | -3,32 -3,73 11.02% | -1,90 -3,41 44.31% | -5,08 -2,49 -104.34% | -2,57 -0,54 -377.3% | -3,25 -4,04 19.6% | -1,99 -2,64 24.63% | -0,85 | -0,22 | -1,01 | 0,09 | 1,80 | 3,30 |
| Announcement Date | 26/02/25 | 01/05/25 | 05/08/25 | 04/11/25 | 19/02/26 | 06/05/26 | 30/07/26 | - | - | - | - | - | - |
| 2026-10-06 |  | Information meeting | 10:00 |
| 2026-10-07 | | Extraordinary General Meeting | 09:00 |
| 2026-10-07 | | Présentation aux Actionnaires / Analystes | 09:00 |
| 2026-10-13 | | Présentation aux Actionnaires / Analystes | |
| 2026-10-13 | | Information meeting | 16:30 |
| 2026-10-13 | | Extraordinary General Meeting | 22:00 |
| 2026-10-14 | | Information meeting | 14:30 |
| 2026-10-14 | | Présentation aux Actionnaires / Analystes | |
| 2026-10-14 | | Sales and Revenue Release - Q3 2026 | |
| 2026-10-14 | | Information meeting | 08:00 |
Past sector events for Madrigal Pharmaceuticals, Inc.
| 2026-10-01 | | Présentation aux Actionnaires / Analystes | 08:00 |
| 2026-09-30 | | Information meeting | 13:00 |
| 2026-09-29 | | Extraordinary General Meeting | 02:00 |
| 2026-09-29 | | Information meeting | 08:00 |
| 2026-09-29 | | Information meeting | 08:30 |
| 2026-09-29 | | Présentation aux Actionnaires / Analystes | 08:00 |
| 2026-09-28 | | Information meeting | 08:30 |
| 2026-09-28 | | Earnings release - Q2 2026 | |
| 2026-09-28 | | Earnings presentation | 08:00 |
| 2026-09-25 | | Earnings presentation | 09:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- MDGL Stock
- YDO1 Stock
- Calendar Madrigal Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
